Clinical, Molecular and Electrophysiological Profiling of Parkinson's Disease: the Role of Non-pharmacological Therapies
NCT ID: NCT05807581
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2023-06-09
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity on Neuroinflammation in Parkinson's Disease
NCT06977204
Movement Improves Brain Health and Cognition in Parkinson's Disease
NCT07299279
Physical Activity in Patients With Parkinson's Disease: a "Disease Modifying" Intervention?
NCT05815524
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
NCT05748028
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NCT07324330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biomarkers
No interventions assigned to this group
physical activity
physical activity
treadmill running 3 times weekly
sedentary
No interventions assigned to this group
iTBS active
iTBS
repetitive TMS stimulation 5 days weekly for two weeks
iTBS sham
iTBS
repetitive TMS stimulation 5 days weekly for two weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical activity
treadmill running 3 times weekly
iTBS
repetitive TMS stimulation 5 days weekly for two weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hoehn \& Yahr (H\&Y) stage between 1 and 3
Exclusion Criteria
* Oncological or autoimmune comorbidities
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS National Neurological Institute "C. Mondino" Foundation
OTHER
Istituto Neurologico Mediterraneo Neuromed S. R. L
OTHER
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
OTHER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Flavia Torlizzi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5478
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.